Elixirr International (LSE:ELIX) YoY EBITDA Growth: 21.89% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:ELIX Elixirr International PLC LSE:ELIX
82 GF Score
Price £5.80
GF Value £11.08
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elixirr International YoY EBITDA Growth?

Elixirr International LSE:ELIX -2.36% 82 YoY EBITDA Growth is 21.89% as of Dec. 2025. GuruFocus rates LSE:ELIX with a GF Score™ of 82/100 and a GF Value™ of £11.08 (Significantly Undervalued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Elixirr International's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 21.89%.

Elixirr International's EBITDA per Share for the six months ended in Dec. 2025 was £0.32.

Elixirr International YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Elixirr International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixirr International YoY EBITDA Growth Chart

Elixirr International Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial 48.44 35.44 32.38 4.89 26.12

Elixirr International Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.79 19.82 -7.02 30.15 21.89
LSE:ELIX
82GF Score
Elixirr International PLC LSE:ELIX
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elixirr International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Elixirr International's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.676-0.536)/ | 0.536 |
=26.12 %

Elixirr International's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(0.323-0.265)/ | 0.265 |
=21.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 21.89% mean?
Elixirr International (LSE:ELIX) has a YoY EBITDA Growth of 21.89% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Elixirr International and its competitors.
Is Elixirr International's YoY EBITDA Growth too high?
Elixirr International's current YoY EBITDA Growth is 21.89%. Overall, Elixirr International has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elixirr International's YoY EBITDA Growth compare to VRSK and EFX?
Elixirr International's YoY EBITDA Growth of 21.89% can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Business Services company?
A good YoY EBITDA Growth depends on the Business Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Elixirr International and its competitors. Elixirr International's current YoY EBITDA Growth is 21.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixirr International stock overvalued right now?
Based on GuruFocus' analysis, Elixirr International (LSE:ELIX) is currently considered Significantly Undervalued. The stock's GF Value™ is £11.08, compared to a current price of £5.80 — trading 47.7% below its estimated fair value. The current YoY EBITDA Growth is 21.89%. Elixirr International's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Elixirr International (LSE:ELIX), the current YoY EBITDA Growth is 21.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elixirr International (LSE:ELIX) Overvalued in 2026?

Based on GuruFocus' analysis, Elixirr International stock appears to be undervalued. The current stock price of £5.80 is trading 47.7% below its estimated GF Value™ of £11.08. GuruFocus considers Elixirr International to be Significantly Undervalued.

Key valuation signals for LSE:ELIX:

  • YoY EBITDA Growth: 21.89%
  • GF Value™: £11.08 vs. price of £5.80 (47.7% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the LSE:ELIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elixirr International Business Description

Address 100 Cheapside, London, GBR, EC2V 6DT
Elixirr International PLC is a provider of management consultancy services. The company is principally engaged in the provision of consulting services, delivering original and bespoke solutions to a globally-recognized client base, including creative, marketing and transformation services. These challenges include future proofing against technological disruption development and roll-out of new products, services and businesses navigating a more complex and multinational regulatory environment; and project management and implementation of change programs. Geographically, the company operates in United Kingdom; USA; and Rest of the World, of which USA derives maximum revenue.
82GF Score

Get the complete analysis for LSE:ELIX

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£5.80
Price
£11.08
GF Value